Literature DB >> 23095409

Advances in peritoneal dialysis in acute kidney injury.

Daniela Ponce1, André Luís Balbi, Richard Amerling.   

Abstract

Peritoneal dialysis (PD) is a simple, safe, cheap, and efficient renal replacement therapy method. It can correct metabolic disorders and fluid overload in acute kidney injury (AKI) patients both in and out of the intensive care unit. Use of PD in AKI is enhanced by placement of a Tenckhoff catheter, which can be safely accomplished at the bedside. Some PD modalities, such as high-volume PD and continuous-flow PD, can provide dialysis doses and efficiency comparable to extracorporeal blood purification methods. PD is particularly suitable for neonates, children, and patients with refractory heart failure or who are otherwise hemodynamically unstable. PD should be considered in situations where systemic anticoagulation and/or vascular access are problematic. PD is limited by a lower efficiency that may produce inadequate renal replacement in larger and/or severely hypercatabolic patients. Fluid removal can be unpredictable, there is a risk of infection, and possible issues with mechanical ventilation. In this article, we discuss the use of PD in AKI, with emphasis on recent advances.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23095409     DOI: 10.1159/000341648

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  11 in total

Review 1.  Peritoneal dialysis for acute kidney injury.

Authors:  Brett Cullis; Mohamed Abdelraheem; Georgi Abrahams; Andre Balbi; Dinna N Cruz; Yaacov Frishberg; Vera Koch; Mignon McCulloch; Alp Numanoglu; Peter Nourse; Roberto Pecoits-Filho; Daniela Ponce; Bradley Warady; Karen Yeates; Fredric O Finkelstein
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

2.  Effect of peritoneal dialysis on respiratory mechanics in acute kidney injury patients.

Authors:  Cibele Puato Almeida; Daniela Ponce; Ana Carolina de Marchi; Andre Luis Balbi
Journal:  Perit Dial Int       Date:  2014 Jul-Aug       Impact factor: 1.756

3.  Effect of peritoneal dialysis vs. haemodialysis on respiratory mechanics in acute kidney injury patients.

Authors:  Cibele Puato Almeida; André Luís Balbi; Daniela Ponce
Journal:  Clin Exp Nephrol       Date:  2018-06-11       Impact factor: 2.801

4.  Metabolic implications of peritoneal dialysis in patients with acute kidney injury.

Authors:  Cassiana Regina Góes; Marina Nogueira Berbel; Andre Luis Balbi; Daniela Ponce
Journal:  Perit Dial Int       Date:  2013 Nov-Dec       Impact factor: 1.756

5.  Recovery from AKI following multiple wasp stings: a case series.

Authors:  Ling Zhang; Yingying Yang; Yi Tang; Yuliang Zhao; Yu Cao; Baihai Su; Ping Fu
Journal:  Clin J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 8.237

6.  Acute Peritoneal Dialysis During the COVID-19 Pandemic at Bellevue Hospital in New York City.

Authors:  Nina J Caplin; Olga Zhdanova; Manish Tandon; Nathan Thompson; Dhwanil Patel; Qandeel Soomro; Fnu Ranjeeta; Leian Joseph; Jennifer Scherer; Shivam Joshi; Betty Dyal; Harminder Chawla; Sitalakshmi Iyer; Douglas Bails; Judith Benstein; David S Goldfarb; Bruce Gelb; Richard Amerling; David M Charytan
Journal:  Kidney360       Date:  2020-10-16

Review 7.  Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials.

Authors:  Amir Kazory
Journal:  World J Cardiol       Date:  2015-07-26

Review 8.  Approach to the Metabolic Implications of Peritoneal Dialysis in Acute Kidney Injury.

Authors:  Cassiana Regina Góes; Marina Nogueira Berbel; Andre Luis Balbi; Daniela Ponce
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

Review 9.  Peritoneal dialysis for acute kidney injury.

Authors:  Linfeng Liu; Ling Zhang; Guan J Liu; Ping Fu
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

10.  Peritoneal Dialysis in Acute Kidney Injury: Trends in the Outcome across Time Periods.

Authors:  Daniela Ponce; Marina Berbel Buffarah; Cassiana Goes; André Balbi
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.